Error message
- Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home3/ran/public_html/includes/common.inc).
- Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home3/ran/public_html/includes/common.inc).
- Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home3/ran/public_html/includes/common.inc).
- Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home3/ran/public_html/includes/common.inc).
Precision Medicine Think Tank Followup
- by EldaRailey - Tue, 04/02/2019 - 02:52
- Precision Medicine, Cancer Clinical Trials, Research Advocacy, Reports
Research Advocacy Network is pleased to announce funding from the ECOG ACRIN Foundation to continue work with advocates to provide input for precision medicine clinical trials. In November 2017 Research Advocacy Network brought together NCI Steering Committee and NCTN advocates at a symposium to learn more about precision medicine trials like NCI-MATCH. On the last day of the symposium, a think tank session was held with advocate attendees to prioritize issues and propose solutions to address in our advocacy roles.
Recently we polled the advocates that attended the 2017 Symposium and Think Tank to gather their opinions about the continued relevance of the issues of precision medicine clinical trials. We are pleased to report the results of the survey. Please download the report to learn more.
Research Advocacy Network starts CONNECT virtual discussion series
- by EldaRailey - Sat, 03/28/2020 - 04:38
- CONNECT, Cancer Clinical Trials
During March, 2020, Research Advocacy Network found ourselves, along with you, in a confusing, scary and often overwhelming world with the coronavirus pandemic. As the situation rapidly changed, we became increasingly more concerned about cancer patients and what was happening during this time for these patients and cancer research. Not only did plans for the scientific meetings where results of research advances get cancelled or postponed, cancer treatment strategies and clinical trial plans had to be adjusted.
